Bluegnome has announced a programme designed to meet the needs of laboratories that are looking to scale up the volume of their arrayCGH investigations.
The company said the 'Upgrade me' plan specifically benefits laboratories that have been using 2 x 105K and 4 x 44K oligo arrays, and wish to improve their data storage, analysis and interpretation capabilities.
Central to the plan is the adoption of Bluegnome's Bluefuse Multi software.
Bluefuse Multi combines automated data analysis with a scalable laboratory database and so provides a centralised repository around which a more efficient laboratory workflow may be planned.
The software enables each new case to be visualised against summary tracks of all other imbalances in the database in order to easily identify recurrent regions of benign copy number variation or locate samples that share low frequency imbalances.
One laboratory that has upgraded using the 'Upgrade me' programme is the University of Nebraska Medical Center.
Dr Warren Sanger, director of cytogenetics at University of Nebraska Medical Center, said: 'We run a very high throughput cytogenetics laboratory, however, for some time it has been apparent that data analysis and interpretation represent the biggest bottleneck in our investigations.
'Within hours of embarking on its 'Upgrade me' plan, Bluegnome had completed the analysis of all our samples, which are now immediately accessible from any workstation in the lab.
'The resulting database already gives us more reliable information on our imbalances than we could hope to obtain from online data sources.
'We are now using the Cytochip Oligo 4 x 44K array, which is compatible with our existing hardware and laboratory workflow.'
All Bluegnome products are supplied for research use only.
